Cargando…

Novel therapeutics and emerging technologies in head and neck cancer

Detalles Bibliográficos
Autor principal: Teknos, Theodoros N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698515/
https://www.ncbi.nlm.nih.gov/pubmed/29204549
http://dx.doi.org/10.1016/j.wjorl.2016.06.001
_version_ 1783280782447476736
author Teknos, Theodoros N.
author_facet Teknos, Theodoros N.
author_sort Teknos, Theodoros N.
collection PubMed
description
format Online
Article
Text
id pubmed-5698515
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-56985152017-12-04 Novel therapeutics and emerging technologies in head and neck cancer Teknos, Theodoros N. World J Otorhinolaryngol Head Neck Surg Foreword KeAi Publishing 2016-07-25 /pmc/articles/PMC5698515/ /pubmed/29204549 http://dx.doi.org/10.1016/j.wjorl.2016.06.001 Text en © 2016 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Foreword
Teknos, Theodoros N.
Novel therapeutics and emerging technologies in head and neck cancer
title Novel therapeutics and emerging technologies in head and neck cancer
title_full Novel therapeutics and emerging technologies in head and neck cancer
title_fullStr Novel therapeutics and emerging technologies in head and neck cancer
title_full_unstemmed Novel therapeutics and emerging technologies in head and neck cancer
title_short Novel therapeutics and emerging technologies in head and neck cancer
title_sort novel therapeutics and emerging technologies in head and neck cancer
topic Foreword
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698515/
https://www.ncbi.nlm.nih.gov/pubmed/29204549
http://dx.doi.org/10.1016/j.wjorl.2016.06.001
work_keys_str_mv AT teknostheodorosn noveltherapeuticsandemergingtechnologiesinheadandneckcancer